Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CHRNB4 antibody (C-Term)

There are 4+ publications for this product available. The Rabbit Polyclonal anti-CHRNB4 antibody is suitable to detect CHRNB4 in samples from Human. It has been validated for WB.
Catalog No. ABIN1881200
$451.00
Plus shipping costs $50.00
Shipping to: United States
Delivery in 10 to 12 Business Days

Quick Overview for CHRNB4 antibody (C-Term) (ABIN1881200)

Target

See all CHRNB4 Antibodies
CHRNB4 (Cholinergic Receptor, Nicotinic, beta 4 (Neuronal) (CHRNB4))

Reactivity

  • 19
  • 4
  • 4
Human

Host

  • 19
  • 3
  • 1
Rabbit

Clonality

  • 21
  • 2
Polyclonal

Conjugate

  • 17
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CHRNB4 antibody is un-conjugated

Application

  • 19
  • 16
  • 6
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

RB42408
  • Binding Specificity

    • 7
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 422-450, C-Term

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogen

    This CHRNB4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 422-450 amino acids from the C-terminal region of human CHRNB4.

    Isotype

    Ig Fraction
  • Application Notes

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Expiry Date

    6 months
  • Zhang, Kranzler, Poling, Gelernter: "Variation in the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 and its interaction with recent tobacco use influence cognitive flexibility." in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Vol. 35, Issue 11, pp. 2211-24, (2010) (PubMed).

    Amos, Gorlov, Dong, Wu, Zhang, Lu, Scheet, Greisinger, Mills, Spitz: "Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study." in: Journal of the National Cancer Institute, Vol. 102, Issue 15, pp. 1199-205, (2010) (PubMed).

    Saccone, Schwantes-An, Wang, Grucza, Breslau, Hatsukami, Johnson, Rice, Goate, Bierut: "Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans." in: Genes, brain, and behavior, Vol. 9, Issue 7, pp. 741-50, (2010) (PubMed).

    Hansen, Xiao, Rice, Bracci, Wrensch, Sison, Chang, Smirnov, Patoka, Seldin, Quesenberry, Kelsey, Wiencke: "Fine mapping of chromosome 15q25.1 lung cancer susceptibility in African-Americans." in: Human molecular genetics, Vol. 19, Issue 18, pp. 3652-61, (2010) (PubMed).

  • Target

    CHRNB4 (Cholinergic Receptor, Nicotinic, beta 4 (Neuronal) (CHRNB4))

    Alternative Name

    CHRNB4

    Background

    After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.

    Molecular Weight

    56380

    NCBI Accession

    NP_000741, NP_001243496

    UniProt

    P30926
You are here:
Chat with us!